Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Hypertension. 2021 Jun 28;78(2):525–531. doi: 10.1161/HYPERTENSIONAHA.119.14483

Table 1.

Patient Characteristics

Parameters MSA
(N=35)
PAF/PD
(N=64)
All patients (N=99)
Age, years 61±7.5 70±8.3 67±9.0
BMI, kg/m2 26±4.1 26±3.50 26±3.7
Sex, female/male 17/18 23/41 40/59
Supine SBP, mm Hg 139±24.6 132±24.2 135±24.4
Supine DBP, mm Hg 84±16.2 77±12.0 80±13.9
Supine, HR, bpm 71±11.9 69±10.8 70±11.2
Upright SBP, mm Hg 90±19.3 81±15.9 85±17.8
Upright DBP, mm Hg 59±10.8 53±10.9 56±11.2
Upright HR, bpm 85±13.7 82±13.4 83±13.4
OHSA, question 1 4.0±3.5 4.4±3.6 4.3±3.5
Supine Norepinephrine, pg/mL 212±126.4 109±92.8 150±125.4
Supine Epinephrine, pg/mL 23±16.0 22±37.0 22±30.9
Upright Norepinephrine, pg/mL 355±235.6 204±192.0 254±218.0
Upright Epinephrine, pg/mL 40±26.0 31±36.2 34±33.2

OHSA, orthostatic hypotension symptom assessment; MSA, multiple system atrophy; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate, BMI, body mass index.